Shielding of virus-like nanoparticles of hepatitis B core antigen by poly(2-oxazoline) for reduced antigenicity
The rapid advances of nanotechnology over the past decades have led to increasing development of nano-sized drug delivery systems for various biomedical applications, including cancer therapies. Virus-like nanoparticles (VLNPs) have received considerable interest as nanocarriers for targeted drug de...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
2021
|
| Linkit: | http://ethesis.upm.edu.my/id/eprint/16295/1/FBSB%202021%2026%20UPMT.pdf |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Lisää ensimmäinen kommentti!